ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: exemestane|DRUG: lapatinib
Sponsor: National Cancer Institute, Naples